Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.

@article{Connolly2009FenfluramineDT,
  title={Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.},
  author={Jeanne M. Connolly and Marina Bakay and James T. Fulmer and Robert C. Gorman and Joseph H. Gorman and Mark A Oyama and Robert J. Levy},
  journal={The American journal of pathology},
  year={2009},
  volume={175 3},
  pages={
          988-97
        }
}
Serotonin (5HT) receptor signaling and 5HT-related agents, such as the anorexogen fenfluramine (Fen), have been associated with heart valve disease. We investigated the hypothesis that Fen may disrupt mitral valve interstitial cell (MVIC) homeostasis through its effects on mitogenesis and extracellular matrix biosynthesis. Normal and myxomatous mitral valves, both human and canine, were harvested, and primary MVIC cultures were established. 5HT caused increased phosphorylation of extracellular… CONTINUE READING
Highly Cited
This paper has 32 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology • 2014
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 44 references

Drugs and valvular heart disease.

The New England journal of medicine • 2007

O’Suilleabhain PE: Cardiac valve re gurgitation with pergolide compared with nonergot agonists in Parkinson disease

RB Dewey
Arch Neurol • 2007
View 1 Excerpt